Publication | Closed Access

Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials

Non-cystic Fibrosis BronchiectasisAllergyPlacebo-controlled Phase 3Advanced Lung DiseaseInhalation SolutionPulmonary FibrosisPulmonary MedicineMedicinePulmonary Disease